Page last updated: 2024-11-07

phosmidosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phosmidosine: from Streptomyces sp. RK-16; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID456511
SCHEMBL ID4346112
MeSH IDM0188236

Synonyms (6)

Synonym
(2s)-n-[[(2r,3s,4r,5r)-5-(6-amino-8-oxo-7h-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-methoxy-phosphoryl]pyrrolidine-2-carboxamide
phosmidosine
(2s)-n-[[(2r,3s,4r,5r)-5-(6-amino-8-oxo-7h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-methoxyphosphoryl]pyrrolidine-2-carboxamide
SCHEMBL4346112
6-amino-9-{5-o-[{[hydroxy(pyrrolidin-2-yl)methylidene]amino}(methoxy)phosphoryl]pentofuranosyl}-9h-purin-8-ol
DTXSID20928838
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (35.71)18.2507
2000's7 (50.00)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (28.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]